Global loss of ASK1 in Map3k5−/− mice resulted in no basal cardiac phenotype but improved function, reduced ventricular dilation, and reduced cardiomyocyte apoptosis following myocardial infarction or pressure overload [95] and reduced hypertrophy following AngII infusion [96]. The gene discussed is MAP3K5; the disease is myocardial infarction.